These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2075851)

  • 1. Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts.
    Strang J; Gossop M
    Addict Behav; 1990; 15(6):541-7. PubMed ID: 2075851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
    Kasvikis Y; Bradley B; Gossop M; Griffiths P; Marks I
    Int J Addict; 1990 Oct; 25(10):1169-78. PubMed ID: 2090621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
    Zarghami M; Masoum B; Shiran MR
    J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
    Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
    Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term detoxification with methadone.
    Senay EC; Dorus W; Showalter CV
    Ann N Y Acad Sci; 1981; 362():203-16. PubMed ID: 7020530
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.
    Gossop M; Bradley B; Phillips GT
    Addict Behav; 1987; 12(1):1-6. PubMed ID: 3565107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone dosage, program policies, and heroin use among methadone patients.
    Newman RG; Des Jarlais DC
    J Subst Abuse Treat; 1992; 9(2):183-4. PubMed ID: 1512805
    [No Abstract]   [Full Text] [Related]  

  • 16. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
    Senay EC; Dorus W; Goldberg F; Thornton W
    Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal from methadone maintenance. Impact of a tapering network support program.
    Sorensen JL; Trier M; Brummett S; Gold ML; Dumontet R
    J Subst Abuse Treat; 1992; 9(1):21-6. PubMed ID: 1593661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial.
    Drummond DC; Turkington D; Rahman MZ; Mullin PJ; Jackson P
    Drug Alcohol Depend; 1989 Jan; 23(1):63-71. PubMed ID: 2646089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum methadone as an aid in managing methadone maintenance patients.
    Walton RG; Thornton TL; Wahl GF
    Int J Addict; 1978 Jul; 13(5):689-94. PubMed ID: 721328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.